A Phase 1 Trial of ASTX030 in Patients With Myelodysplastic Syndrome
A Phase 1 Trial of ASTX030 in Patients With Myelodysplastic Syndrome
Recruiting · NCT04608110 · Registry updated 2026-08-10Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Phase 1 Trial of ASTX030 in Patients With Myelodysplastic Syndrome | Hemic and Lymphatic Diseases, bone marrow disorder, hematologic disorder, myelodysplastic syndrome | Recruiting | Phase 1 | 2026-08-10 | NCT04608110 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Taiho Pharmaceutical Co., Ltd. | 8 |
10 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Fukushima Medical University Hospital | Fukushima | Japan | 12 |
| Kindai University Hospital | Sakai | Japan | 2 |
| Nagasaki University Hospital | Nagasaki | Japan | 5 |
| Nippon Medical School Hospital | Bunkyō City | Japan | 2 |
| NTT Medical Center Tokyo | Shinagawa-Ku | Japan | 1 |
| Osaka City General Hospital | Osaka | Japan | 10 |
| Saitama Medical University Hospital | Iruma | Japan | 1 |
| Tokyo Medical University Hospital | Shinjuku-Ku | Japan | 1 |
| University Hospital, Kyoto Prefectural University of Medicine | Kyoto | Japan | 2 |
| Yamagata University Hospital | Yamagata | Japan | 6 |